MicroRNA-193b-3p acts as a tumor suppressor by targeting the MYB oncogene in T-cell acute lymphoblastic leukemia

Leukemia

Volumn 29, Issue 4, 2015, Pages 798-806

  Mets, E ^a   Van Der Meulen, J ^a   Van Peer, G ^a   Boice, M ^b   Mestdagh, P ^a   Van De Walle, I ^a   Lammens, T ^a   Goossens, S ^c   De Moerloose, B ^a   Benoit, Y ^a   Van Roy, N ^a   Clappier, E ^d   Poppe, B ^a   Vandesompele, J ^a   Wendel, H G ^b   Taghon, T ^a   Rondou, P ^a   Soulier, J ^d   Van Vlierberghe, P ^a   Speleman, F ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c GHENT UNIVERSITY   (Belgium)

^d SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 193B 3P; PROTEIN MYB; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CELL CYCLE PROTEIN; F BOX PROTEIN; FBXW7 PROTEIN, HUMAN; MIRN193 MICRORNA, HUMAN; MIRN223 MICRORNA, HUMAN; ONCOPROTEIN; PROTEIN C MYB; TAL1 PROTEIN, HUMAN; UBIQUITIN PROTEIN LIGASE;

3' UNTRANSLATED REGION; ACUTE LYMPHOBLASTIC LEUKEMIA; ANIMAL CELL; ARTICLE; CANCER PATIENT; COHORT ANALYSIS; CONTROLLED STUDY; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; ONCOGENE MYB; PEPTIDE LIBRARY; PRIORITY JOURNAL; T CELL ACUTE LYMPHOBLASTIC LEUKEMIA; T CELL LEUKEMIA; T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; TUMOR SUPPRESSOR GENE; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE LIBRARY; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

3' UNTRANSLATED REGIONS; ANIMALS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; F-BOX PROTEINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, LEUKEMIC; GENOMIC LIBRARY; HUMANS; MICE; MICRORNAS; PRECURSOR T-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PRIMARY CELL CULTURE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYB; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TRANSCRIPTOME; UBIQUITIN-PROTEIN LIGASES;

EID: 84927674695     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2014.276     Document Type: Article

References (47)

1. Van Vlierberghe P, Ferrando A. The molecular basis of T cell acute lymphoblastic leukemia. J Clin Invest 2012; 122: 3398-3406.
2. Weng AP, Ferrando AA, Lee W, Morris JPt, Silverman LB, Sanchez-Irizarry C et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004; 306: 269-271.
3. O'Neil J, Grim J, Strack P, Rao S, Tibbitts D, Winter C et al. FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to gammasecretase inhibitors. J Exp Med 2007; 204: 1813-1824.
4. Ferrando AA, Neuberg DS, Staunton J, Loh ML, Huard C, Raimondi SC et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002; 1: 75-87.
5. Soulier J, Clappier E, Cayuela JM, Regnault A, Garcia-Peydro M, Dombret H et al. HOXA genes are included in genetic and biologic networks defining human acute T-cell leukemia (T-ALL). Blood 2005; 106: 274-286.
6. Homminga I, Pieters R, Langerak AW, De Rooi JJ, Stubbs A, Verstegen M et al. Integrated transcript and genome analyses reveal NKX2-1 and MEF2C as potential oncogenes in T cell acute lymphoblastic leukemia. Cancer Cell 2011; 19: 484-497.
7. Clappier E, Cuccuini W, Kalota A, Crinquette A, Cayuela JM, Dik WA et al. The C-MYB locus is involved in chromosomal translocation and genomic duplications in human T-cell acute leukemia (T-ALL), the translocation defining a new T-ALL subtype in very young children. Blood 2007; 110: 1251-1261.
8. Lahortiga I, De Keersmaecker K, Van Vlierberghe P, Graux C, Cauwelier B, Lambert F et al. Duplication of the MYB oncogene in T cell acute lymphoblastic leukemia. Nat Genet 2007; 39: 593-595.
9. Sanda T, Lawton LN, Barrasa MI, Fan ZP, Kohlhammer H, Gutierrez A et al. Core transcriptional regulatory circuit controlled by the TAL1 complex in human T cell acute lymphoblastic leukemia. Cancer Cell 2012; 22: 209-221.
10. Mansour MR, Sanda T, Lawton LN, Li X, Kreslavsky T, Novina CD et al. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia. J Exp Med 2013; 210: 1545-1557.
11. Correia NC, Durinck K, Leite AP, Ongenaert M, Rondou P, Speleman F et al. Novel TAL1 targets beyond protein-coding genes: Identification of TAL1-regulated microRNAs in T-cell acute lymphoblastic leukemia. Leukemia 2013; 27: 1603-1606.
12. Emambokus N, Vegiopoulos A, Harman B, Jenkinson E, Anderson G, Frampton J. Progression through key stages of haemopoiesis is dependent on distinct threshold levels of c-Myb. EMBO J 2003; 22: 4478-4488.
13. Sakamoto H, Dai G, Tsujino K, Hashimoto K, Huang X, Fujimoto T et al. Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development. Blood 2006; 108: 896-903.
14. Badiani PA, Kioussis D, Swirsky DM, Lampert IA, Weston K. T-cell lymphomas in v-Myb transgenic mice. Oncogene 1996; 13: 2205-2212.
15. Hess JL, Bittner CB, Zeisig DT, Bach C, Fuchs U, Borkhardt A et al. c-Myb is an essential downstream target for homeobox-mediated transformation of hematopoietic cells. Blood 2006; 108: 297-304.
16. Bartel DP. MicroRNAs: Target recognition and regulatory functions. Cell 2009; 136: 215-233.
17. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002; 99: 15524-15529.
18. Mavrakis KJ, Wolfe AL, Oricchio E, Palomero T, De Keersmaecker K, McJunkin K et al. Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia. Nat Cell Biol 2010; 12: 372-379.
19. Mavrakis KJ, Van Der Meulen J, Wolfe AL, Liu X, Mets E, Taghon T et al. A cooperative microRNA-tumor suppressor gene network in acute T-cell lymphoblastic leukemia (T-ALL). Nat Genet 2011; 43: 673-678.
20. Li X, Sanda T, Look AT, Novina CD, Von Boehmer H. Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL. J Exp Med 2011; 208: 663-675.
21. Jackson AL, Levin AA. Developing microRNA therapeutics: Approaching the unique complexities. Nucleic Acid Ther 2012; 22: 213-225.
22. Taghon T, Waegemans E, Van De Walle I. Notch signaling during human T cell development. Curr Top Microbiol Immunol 2012; 360: 75-97.
23. Clappier E, Gerby B, Sigaux F, Delord M, Touzri F, Hernandez L et al. Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse. J Exp Med 2011; 208: 653-661.
24. Huber W, Von Heydebreck A, Sultmann H, Poustka A, Vingron M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 2002; 18 (Suppl 1): S96-104.
25. Xiao C, Calado DP, Galler G, Thai TH, Patterson HC, Wang J et al. MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb. Cell 2007; 131: 146-159.
26. Cesi V, Casciati A, Sesti F, Tanno B, Calabretta B, Raschella G. TGFbeta-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells. Cell Cycle 2011; 10: 4149-4161.
27. Imig J, Motsch N, Zhu JY, Barth S, Okoniewski M, Reineke T et al. microRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res 2011; 39: 1880-1893.
28. Luo Z, Zhang L, Li Z, Li X, Li G, Yu H et al. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med Genomics 2012; 5: 3.
29. Grabher C, Payne EM, Johnston AB, Bolli N, Lechman E, Dick JE et al. Zebrafish microRNA-126 determines hematopoietic cell fate through c-Myb. Leukemia 2011; 25: 506-514.
30. Chung EY, Dews M, Cozma D, Yu D, Wentzel EA, Chang TC et al. c-Myb oncoprotein is an essential target of the dleu2 tumor suppressor microRNA cluster. Cancer Biol Ther 2008; 7: 1758-1764.
31. Siebzehnrubl FA, Silver DJ, Tugertimur B, Deleyrolle LP, Siebzehnrubl D, Sarkisian MR et al. The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance. EMBO Mol Med 2013; 5: 1196-1212.
32. Taghon T, Waegemans E, Van De Walle I. Notch signaling during human T cell development. In: Radtke F (ed). Notch Regulation of the Immune System. Springer: Berlin, Heidelberg, Germany, 2012, pp 75-97.
33. Braconi C, Valeri N, Gasparini P, Huang N, Taccioli C, Nuovo G et al. Hepatitis C virus proteins modulate microRNA expression and chemosensitivity in malignant hepatocytes. Clin Cancer Res 2010; 16: 957-966.
34. Chen J, Zhang X, Lentz C, Abi-Daoud M, Pare GC, Yang X et al. miR-193b regulates Mcl-1 in melanoma. Am J Pathol 2011; 179: 2162-2168.
35. Pear WS, Aster JC, Scott ML, Hasserjian RP, Soffer B, Sklar J et al. Exclusive development of T cell neoplasms in mice transplanted with bone marrow expressing activated Notch alleles. J Exp Med 1996; 183: 2283-2291.
36. Beug H, Von Kirchbach A, Doderlein G, Conscience JF, Graf T. Chicken hematopoietic cells transformed by seven strains of defective avian leukemia viruses display three distinct phenotypes of differentiation. Cell 1979; 18: 375-390.
37. Gewirtz AM. Myb targeted therapeutics for the treatment of human malignancies. Oncogene 1999; 18: 3056-3062.
38. Amaru Calzada A, Todoerti K, Donadoni L, Pellicioli A, Tuana G, Gatta R et al. The HDAC inhibitor Givinostat modulates the hematopoietic transcription factors NFE2 and C-MYB in JAK2(V617F) myeloproliferative neoplasm cells. Exp Hematol 2012; 40: 634-645, e610.
39. Chambers AE, Banerjee S, Chaplin T, Dunne J, Debernardi S, Joel SP et al. Histone acetylation-mediated regulation of genes in leukaemic cells. Eur J Cancer 2003; 39: 1165-1175.
40. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 2009; 137: 1005-1017.
41. Cheng J, Guo S, Chen S, Mastriano SJ, Liu C, D'Alessio AC et al. An extensive network of TET2-targeting microRNAs regulates malignant hematopoiesis. Cell Rep 2013; 5: 471-481.
42. Zhou P, Xu W, Peng X, Luo Z, Xing Q, Chen X et al. Large-scale screens of miRNAmRNA interactions unveiled that the 3'UTR of a gene is targeted by multiple miRNAs. PLoS One 2013; 8: E68204.
43. Ramsay RG, Gonda TJ. MYB function in normal and cancer cells. Nat Rev Cancer 2008; 8: 523-534.
44. Bender TP, Kremer CS, Kraus M, Buch T, Rajewsky K. Critical functions for c-Myb at three checkpoints during thymocyte development. Nat Immunol 2004; 5: 721-729.
45. Allen RD 3rd, Bender TP, Siu G. c-Myb is essential for early T cell development. Genes Dev 1999; 13: 1073-1078.
46. Cobb BS, Nesterova TB, Thompson E, Hertweck A, O'Connor E, Godwin J et al. T cell lineage choice and differentiation in the absence of the RNase III enzyme Dicer. J Exp Med 2005; 201: 1367-1373.
47. Inuzuka H, Shaik S, Onoyama I, Gao D, Tseng A, Maser RS et al. SCF(FBW7) regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature 2011; 471: 104-109.